PLT‐associated immunoglobulin increases during PLT storage
PLT‐associated immunoglobulin increases during PLT storage
复制标题
PLT 储存期间 PLT 相关免疫球蛋白增加
DOI:
10.1046/j.1537-2995.2003.00535.x
复制
发表时间:
2003
期刊:
影响因子:
2.9
通讯作者:
T. Koerner
中科院分区:
文献类型:
--
作者:
L. Cooling;T. Koerner
Strategies for preventing posttransfusion CMV infections include testing for CMV antibodies, CMV DNA, and/or WBC reduction of blood components. 1, 2 Early studies with molecular methods produced conflicting results. Nevertheless, recent investigations show that improved CMV PCR assays do not necessarily increase detection of CMV DNA in healthy CMV-seronegative blood donors. 3, 4 We confirm these findings in a study of 244 plasma and WBC fractions and 176 serum samples from 420 donors in the Vienna, Austria, region (384 randomly selected and 36 samples selected for IgM anti-CMV reactivity). We tested for IgM and IgG CMV antibodies in serum or plasma with two ELISAs (Enzygnost anti-CMV IgM and Enzygnost anti-CMV IgG, Dade Behring, Marburg, Germany). Results were interpreted to be positive if the corrected absorbance values (DA=[Aantigen–Acontrol antigen]¥ correction factor) were greater than the cutoff of 0.2 OD, negative if the absorbance values were less than the cutoff of 0.1 OD, and equivocal if the absorbance values were between 0.1 and 0.2 OD in the first test and in retesting. CMV PCR screening was performed on serum, plasma, and WBC samples with a 5¢-nuclease real-time PCR assay, which targets the polymerase gene region of the virus. PCR-reactive samples were retested and confirmed with a second real-time assay amplifying a sequence stretch in the major immediate early region. In serial dilutions of the quantitated plasma sample VQC 1999/6, the 95 percent cutoff value of the screening assay had been estimated to be four copies per PCR (192 copies/mL). CMV DNA was reproducibly detected and confirmed in the WBC fraction from one donor and a serum sample from another donor. CMV DNA was not detected in the plasma or whole blood corresponding to the CMV DNA-positive WBCs. We interpret these results to indicate that this sample was most probably from a latently infected individual. The viral loads in these samples were approximately 10 times lower (approx., 100 copies/mL) than the positive control for the assay (1000 copies/mL). The above findings correlate well with those of Roback and colleagues. 4 In their study, 10 to 99 CMV geq per 250,000 WBCs were detectable in 2 of 1000 whole blood samples. Both samples were reactive for anti-CMV but there was no differentiation between IgM and IgG reactivity. We also found our positive DNA results only in seropositive samples, in the strict sense restricted to IgG-positive and either IgM-equivocal or IgM-negative seroreactivity (Table 1).
DOI:
--
发表时间:
1988
期刊:
Blood cells
影响因子:
--
作者:
Aminoff,D
通讯作者:
Aminoff,D